Equities

Orthofix Medical Inc

Orthofix Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)19.98
  • Today's Change0.57 / 2.94%
  • Shares traded451.16k
  • 1 Year change+99.80%
  • Beta1.0802
Data delayed at least 15 minutes, as of Nov 11 2024 15:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

  • Revenue in USD (TTM)771.65m
  • Net income in USD-120.49m
  • Incorporated2018
  • Employees1.63k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AxoGen Inc173.48m-16.54m554.89m426.00--5.80--3.20-0.3829-0.38294.012.180.91171.627.43407,237.10-8.69-13.92-9.93-15.8476.9879.74-9.53-20.282.32-2.940.3297--14.7413.6324.98--17.70--
Butterfly Network Inc76.22m-98.51m558.22m225.00--3.07--7.32-0.4708-0.47080.36270.85370.25430.64164.45338,755.60-32.87---38.53--29.60---129.25--2.95--0.00---10.21--20.76------
Quanterix Corp129.33m-39.71m579.52m441.00--1.72--4.48-1.04-1.043.408.770.30782.374.60293,265.30-9.45-15.96-10.30-17.6657.4252.79-30.71-53.798.99--0.00--15.9626.6066.56--20.07--
Varex Imaging Corp832.70m34.20m581.60m2.30k31.090.99978.550.69850.45740.457416.4614.220.67581.955.28346,958.302.820.99133.331.1832.1631.704.171.361.892.000.4271--3.962.9359.0818.880.2924--
Paragon 28 Inc235.44m-59.07m597.06m430.00--4.07--2.54-0.7132-0.71322.841.760.77030.60496.63547,539.60-19.33---23.48--76.67---25.09--1.70-5.300.4295--19.30--28.94------
Simulations Plus Inc70.01m9.95m613.86m243.0062.503.3639.308.770.48940.48943.459.100.3659--5.55288,119.305.206.105.556.4561.6374.0114.2218.97----0.0045.6417.5215.56-0.07033.0117.070.00
Orthopediatrics Corp189.67m-28.44m622.79m247.00--1.68--3.28-1.24-1.248.2615.320.41160.45094.71767,906.90-6.17-5.40-6.78-5.9373.6875.09-15.00-15.923.68-29.110.1638--21.6220.91-1,767.25--28.29--
Pacific Biosciences of California Inc188.87m-400.38m626.82m796.00--1.27--3.32-1.50-1.500.70991.810.11252.056.69237,275.10-23.85-16.19-26.63-17.8126.0137.35-211.99-136.217.14-22.460.6444--56.2920.592.39--36.68--
SI-Bone Inc150.71m-40.85m638.75m344.00--3.86--4.24-1.00-1.003.703.970.65861.546.67438,107.60-17.85-27.88-19.57-30.9477.6985.03-27.10-51.098.12--0.18--30.5220.1929.25--52.62--
Mesa Laboratories Inc223.71m-250.31m642.83m736.00--4.26--2.87-46.43-46.4341.4327.870.41312.516.29303,956.50-46.23-9.20-50.62-9.8862.2760.60-111.89-28.331.371.330.5848---1.3215.95-27,438.28--15.260.00
Iradimed Corp71.31m18.63m715.67m148.0038.678.5836.7910.041.461.465.596.590.78511.426.16481,791.5020.5113.1622.4814.5877.1476.5526.1221.467.82143.270.0068.1323.0016.5934.0222.2297.77--
Orthofix Medical Inc771.65m-120.49m741.74m1.63k--1.41--0.9458-3.21-3.2120.5514.350.86541.176.49479,956.60-13.51-8.88-16.22-10.9667.1872.37-15.62-9.281.13-4.940.2005--62.0610.51-666.60--30.01--
Standard Biotools Inc155.90m-170.60m800.36m534.00--1.64--5.13-0.7091-0.70910.55791.310.30542.486.01291,951.30-24.41-28.17-29.37-33.6048.5751.58-79.91-74.853.41--0.1014--8.57-1.2060.73--50.06--
Figs Inc548.65m10.84m816.71m354.0081.002.0149.311.490.0590.0593.082.381.111.3365.261,549,845.002.20--2.64--67.67--1.97--3.28--0.00--7.87--6.85------
Embecta Corp1.12bn69.70m896.69m2.20k12.88--8.280.80141.211.2119.36-13.240.88822.1111.60508,590.905.53--7.91--66.42--6.23--1.612.061.88---0.7703---68.52------
Cytek Biosciences Inc201.21m-10.16m927.11m645.00--2.37--4.61-0.0782-0.07821.522.970.39821.603.72297,647.90-2.01---2.29--54.92---5.05--5.47--0.0032--17.67---571.58------
Data as of Nov 11 2024. Currency figures normalised to Orthofix Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

62.42%Per cent of shares held by top holders
HolderShares% Held
Armistice Capital LLCas of 30 Jun 20243.75m9.82%
Rubric Capital Management LPas of 30 Jun 20243.69m9.68%
Engine Capital Management LPas of 30 Jun 20243.37m8.82%
BlackRock Fund Advisorsas of 30 Jun 20242.79m7.30%
Paradigm Capital Management, Inc.as of 30 Jun 20242.56m6.70%
The Vanguard Group, Inc.as of 30 Jun 20242.02m5.30%
Morgan Stanley & Co. LLCas of 30 Jun 20241.97m5.16%
Newtyn Management LLCas of 30 Jun 20241.67m4.37%
Glenview Capital Management LLCas of 30 Jun 20241.11m2.90%
SSgA Funds Management, Inc.as of 30 Jun 2024907.69k2.38%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.